Ant Group IPO: Valuation Insights
Ant has launched its concurrent Hong Kong and STAR Market IPO to raise $34.4 billion. Overall, we think that the IPO price is reasonable for a...
366 Views
Ant Group Pre-IPO: Updated Valuation. It’s Going Higher.
Ant Group plans to raise up to US$35bn via in its Hong Kong Exchange and Shanghai STAR board listing. We have covered various aspects of the deal...
452 Views
ECM Weekly (25 October 2020) - Ant Group, Lufax, JW Thera, Shimao Svcs, GDS Secondary, Nanofilm
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...
326 Views
Lufax IPO: Valuation Insights
Our valuation analysis suggests that the IPO price range is unattractive and we would be inclined to give the IPO a pass.
577 Views
Lufax IPO - Stuck with the Earlier Fundraising Valuation
Lufax Holdings (LU US) aims to raise around US$2.4bn via its US listing. The company is backed by Ping An Insurance and has undergone major changes...
411 Views